Navigation Links
Genmab Announces 2008 First Quarter Results
Date:5/28/2008

Summary: Genmab Reports Results for the First Three Months of 2008.

COPENHAGEN, May 28 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today results for the three month period ended March 31, 2008. During this period, Genmab reported the following results:

Genmab's revenues were DKK 167 million (approx. USD 36 million) for the first quarter of 2008. In the same period of 2007, Genmab recognized revenues of DKK 80 million (approx. USD 17 million).

An operating loss of DKK 197 million (approx. USD 42 million). This compares to an operating loss of DKK 106 million (approx. USD 22 million) reported for the corresponding period of 2007.

Net financial income for the first quarter of 2008 reflected a net loss of DKK 14 million (approx. USD 3 million) compared to a net income of DKK 29 million (approx. USD 6 million) in the same period of 2007. The net financial income reflects a combination of positive yield from our portfolios of marketable securities and unrealized foreign exchange losses derived from the continued weakening of the USD against the DKK in the first quarter of 2008.

A net loss of DKK 210 million (approx. USD 45 million) compared to a net loss of DKK 77 million (approx. USD 16 million) for the same period in 2007. The net loss per share was DKK 4.73 (approx. USD 1.00) for the first quarter of 2008 compared to DKK 1.81 (approx. USD 0.38) in the first quarter of 2007.

Genmab ended the first quarter with a cash position of DKK 2.4 billion (approx. USD 503 million), which is a decrease of DKK 1.3 billion (approx. USD 280 million) from the end of 2007. The decrease primarily arises from the DKK 1.2 billion (approx. USD 240 million at the date of acquisition) acquisition of the manufacturing facility in March 2008.

Highlights During the first quarter of 2008, Genmab achieved a number of business and scientific milestones, as follows:

In March, Genmab acquired an antibody manufacturing facili
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Passing of Genmab A/S Annual General Meeting
2. Genmab A/S - Notice to Convene Annual General Meeting
3. Genmabs 2007 Annual Report
4. Genmab Announces Year End 2007 Financial Results
5. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
6. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
7. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Genmabs Financial Calendar for 2008
10. Genmab Reaches Milestones in Ofatumumab Collaboration
11. Genmab Announces HuMax-CD32b Pre-Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... (PRWEB) May 20, 2013 Kitware, a ... visualization tool that enables the exploration of hospital ... created in response to the recent release of “Medicare ... the top 100 most-billed procedures from the Centers for ... costs for similar procedures at hospitals across the country ...
(Date:5/20/2013)... 2013 In Early 2013, Dr. ... biotoxin related illnesses , announced his vision for creating ... advance his protocol for treating Chronic Inflammatory Response Syndrome ... physician to achieve certification in the Shoemaker Protocol. ... practice the Shoemaker Protocol in other parts of the ...
(Date:5/20/2013)... The World Molecular Imaging Society (WMIS) Board ... as Executive Director. Baird will assume leadership of ... WMIS vision is to encompass and promote preclinical and ... diseases in the developed and developing world. The ... by integrating the Academy of Molecular Imaging and the ...
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... largest solar boat, today announced a new speed record ... Having left from Las Palmas, Spain, on April 25, ... across the Atlantic Ocean at the average speed of ... French West Indies on May 18, 2013. The first-of-its-kind ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2WMIS Appoints Lisa Baird as Next Executive Director 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6
... International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the ... products located in the People,s Republic of China, today ... retail stores in its sales network set a new ... in Qianjiang City in Hubei Province sold 15,310 bottles ...
... Sinovac Biotech Ltd. (NYSE Amex: SVA ), ... announced that it has filed its Annual Report on Form ... year ended December 31, 2008 on May 1, 2009. ... the Company,s website under the investor relations section at: ...
... BONITA SPRINGS, Fla., May 1 Tigris Pharmaceuticals, Inc., ... dosing has started in a Phase I clinical trial ... of geranylgeranyltransferase I (GGTase I) that induces apoptosis by ... I study is led by Dr. Peter O,Dwyer, Professor ...
Cached Biology Technology:Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day 2Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day 3Sinovac Biotech Ltd. Files Annual Report on Form 20-F 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 3
(Date:5/16/2013)... our pulses outside of the gym. But doctors use the ... , Zhenan Bao, a professor of chemical engineering at Stanford, ... and no wider than a postage stamp. The flexible skin-like ... sensitive enough to help doctors detect stiff arteries and cardiovascular ... continuously track heart health and provide doctors a safer method ...
(Date:5/16/2013)... , May 16, 2013 The ... Award on Tuesday to Germany,s ... biometric border control system. DERMALOG has been ... Best Practices Award in the category Global Biometrics and ... edge Biometric   Border Control System . One ...
(Date:5/15/2013)... "keystone" molecules that have powerful behavioral effects on ... in structuring ecosystems, according to a theory proposed ... The authors of the theory, Ryan P. Ferrer ... of the University of California at Los Angeles, ... plants that may be uncommon but exert a ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... claims advising breastfeeding moms that alcoholic beverages can improve ... Center report that even moderate doses of alcohol affect ... , "This information is important for women," comments lead ... is drinking alcohol just to improve the quality or ...
... for the first time that human eggs may develop ... from adult human ovaries. Oocytes derived from the culture ... suitable for fertilization and development into an embryo. These ... Biology and Endocrinology, offer important new strategies for use ...
... St. Louis have learned that a temporal "window of ... diabetic rats with embryonic pig tissues. , In those ... that they didn't have to give anti-rejection drugs to ... had expected rats that received no immune suppression would ...
Cached Biology News:Alcohol consumption disrupts breastfeeding hormones 2Alcohol consumption disrupts breastfeeding hormones 3Human Eggs Can Develop From Ovarian Surface Cells In Vitro 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
Adducin beta (C-16)...
Geneticin Selective Antibiotic liquid...
...
Biology Products: